Clinical study of new tetravalent (type A, B, E, and F) botulinum toxoid vaccine derived from M toxin in Japan.

This study indicated that the vaccine has marked immunogenicity and safety for humans.
PMID: 28250257 [PubMed - as supplied by publisher]

Source: Japanese Journal of Infectious Diseases - February 27, 2017 Category: Infectious Diseases Authors: Torii Y, Sugimoto N, Kohda T, Kozaki S, Morokuma K, Horikawa Y, Ginnaga A, Yamamoto A, Takahashi M Tags: Jpn J Infect Dis Source Type: research